|
|
Volumn 305, Issue 5683, 2004, Pages 460-
|
|
Synthetic vaccine is a sweet victory for Cuban science
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
MENINGITIS VACCINE;
PNEUMOCOCCUS VACCINE;
POLYSACCHARIDE VACCINE;
TETANUS TOXOID;
BACTERIAL POLYSACCHARIDE;
BACTERIUM ANTIBODY;
GLYCOCONJUGATE;
HAEMOPHILUS VACCINE;
VACCINE;
ACHIEVEMENT;
ANTIBODY RESPONSE;
BACTERIAL INFECTION;
BIOTECHNOLOGY;
CUBA;
DRUG APPROVAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG SAFETY;
GOVERNMENT;
HAEMOPHILUS INFLUENZAE;
HEALTH PROGRAM;
HUMAN;
MEDICAL RESEARCH;
NOTE;
PRIORITY JOURNAL;
ADULT;
ANIMAL;
BIOSYNTHESIS;
CHILD;
HAEMOPHILUS INFLUENZAE TYPE B;
IMMUNOLOGY;
SYNTHESIS;
BACTERIA (MICROORGANISMS);
HAEMOPHILUS;
HAEMOPHILUS INFLUENZAE;
HAEMOPHILUS INFLUENZAE SEROTYPE B;
ADULT;
ANIMALS;
ANTIBODIES, BACTERIAL;
BIOTECHNOLOGY;
CHILD;
CUBA;
GLYCOCONJUGATES;
HAEMOPHILUS INFLUENZAE TYPE B;
HAEMOPHILUS VACCINES;
HUMANS;
POLYSACCHARIDES, BACTERIAL;
TETANUS TOXOID;
VACCINES, CONJUGATE;
|
|
EID: 3242882537
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.305.5683.460 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|